|Bid||11.7600 x 900|
|Ask||16.0000 x 1200|
|Day's Range||12.1500 - 12.1500|
|52 Week Range||10.4400 - 25.5500|
|Beta (3Y Monthly)||-0.26|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The biotech sector was in focus last week with Protagonist's stock plunging on news of discontinuation of a phase IIb study and Verona Pharma stock surging on positive top-line data from COPD study among others.
Verona Pharma plc (AIM:VRP), a pharmaceuticals company based in United Kingdom, saw a double-digit share price rise of over 10% in the past couple of months on the AIM. WithRead More...